Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients

Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers

Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases

Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease

Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve

An autologous colonic organoid-derived monolayer model to study immune

Effect of risankizumab on health-related quality of life in patients with Crohn's disease

Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease

Prediction of Crohn’s Disease Stricturing Phenotype Using a NOD2-derived Genomic Biomarker

New endoscopic tools in inflammatory bowel disease

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease

Real world population pharmacokinetic study in children and young adults with inflammatory bowel